Robert A Hauser Selected Research

Parkinson Disease (Parkinson's Disease)

07/2008	Caffeine and progression of Parkinson disease.
05/2008	Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease.
01/2008	Levodopa-induced dyskinesias in Parkinson's disease: etiology, impact on quality of life, and treatments.
12/2007	Ten-year follow-up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa.
07/2007	Levodopa-induced dyskinesia in Parkinson's disease: epidemiology, etiology, and treatment.
04/2007	Duodenal levodopa infusion for the treatment of Parkinson's disease.
02/2007	Randomized trial of the triple monoamine reuptake inhibitor NS 2330 (tesofensine) in early Parkinson's disease.
09/2006	Long-term care of Parkinson's disease. Strategies for managing "wearing off" symptom re-emergence and dyskinesias.
05/2006	The controversy concerning plasma homocysteine in Parkinson disease patients treated with levodopa alone or with entacapone: effects of vitamin status.
01/2006	Tegaserod (Zelnorm) for the treatment of constipation in Parkinson's disease.
09/2005	Open-label pilot study of levetiracetam (Keppra) for the treatment of levodopa-induced dyskinesias in Parkinson's disease.
01/2005	Adenosine A2A receptor antagonists for Parkinson's disease: rationale, therapeutic potential and clinical experience.
08/2004	Double-blind, randomized, controlled trial of rasagiline as monotherapy in early Parkinson's disease patients.
07/2004	Ropinirole therapy for Parkinson's disease.
04/2004	Zydis selegiline reduces off time in Parkinson's disease patients with motor fluctuations: a 3-month, randomized, placebo-controlled study.
07/2003	Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study.
01/2003	Sleep attacks and dopamine agonists for Parkinson's disease: what is currently known?
11/2002	Clozapine withdrawal symptoms in a Parkinson's disease patient.
09/2002	Quantitative description of loss of clinical benefit following withdrawal of levodopa-carbidopa and bromocriptine in early Parkinson's disease.

Articles by Research Topic

Disease

19	Parkinson Disease (Parkinson's Disease) 07/2008 - 09/2002
7	Essential Tremor (Essential Tremors) 01/2008 - 05/2005
5	Chorea (Rheumatic Chorea) 03/2008 - 06/2005
5	Dyskinesias (Dyskinesia) 01/2008 - 09/2005
3	Huntington Disease (Huntington's Disease) 11/2006 - 06/2002
2	Syndrome 03/2008 - 12/2004
2	Torticollis (Wryneck) 07/2005 - 09/2004
1	Stiff-Person Syndrome (Stiff Man Syndrome) 09/2008
1	Pain (Aches) 03/2008
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2008
1	Constipation 01/2006
1	Dystonia (Limb Dystonia) 11/2005
1	Parkinsonian Disorders (Parkinsonism) 07/2005
1	Cerebral Palsy (Spastic Diplegia) 06/2005
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 11/2002

Drug/Important Bio-Agent (IBA)

9	etiracetam (levetiracetam)FDA LinkGeneric 09/2008 - 12/2004
8	Levodopa (L Dopa)FDA LinkGeneric 01/2008 - 09/2002
3	ropinirole (Requip)FDA LinkGeneric 12/2007 - 07/2003
2	pregabalin (Lyrica)FDA Link 08/2007 - 01/2007
2	topiramate (Topamax)FDA Link 05/2006 - 04/2006
1	Caffeine (No Doz)FDA LinkGeneric 07/2008
1	gabapentin (Neurontin)FDA LinkGeneric 03/2008
1	tiagabine (Gabitril)FDA Link 10/2007
1	TesofensineIBA 02/2007
1	zonisamide (Zonegran)FDA LinkGeneric 01/2007
1	HomocysteineIBA 05/2006
1	VitaminsIBA 05/2006
1	entacapone (Comtan)FDA Link 05/2006
1	lamotrigine (Lamictal)FDA LinkGeneric 04/2006
1	tegaserod (Zelnorm)FDA Link 01/2006
1	Botulinum Toxin Type A (Botox)FDA Link 07/2005
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 01/2005
1	Botulinum Toxins (Botulinum Toxin)IBA 09/2004
1	rasagiline (Azilect)FDA Link 08/2004
1	Selegiline (E250)FDA LinkGeneric 04/2004
1	Dopamine Agonists (Dopamine Agonist)IBA 01/2003
1	Clozapine (Clozaril)FDA LinkGeneric 11/2002
1	Bromocriptine (Parlodel)FDA LinkGeneric 09/2002
1	Carbidopa (Lodosyn)FDA LinkGeneric 09/2002

Therapy/Procedure

2	Deep Brain Stimulation 01/2008 - 08/2006
1	Transplants (Transplant) 05/2008
1	Long-Term Care 09/2006
1	Transplantation (Transplant Recipients) 06/2002